Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science



Rating:

Share or cite this content

Citations should be made in the following way:
W. Liao (Singapore, Singapore), Y. Foo (Singapore, Singapore), W. Wong (Singapore, Singapore). Calcaratarin D attenuates house dust mite-induced allergic asthma. 548

Member's Comments

No comment yet.

Related content which might interest you: Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Circulating platelets activity in patients sensitised to house dust mite suffering from persistent allergic rhinitis with or without asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005 The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005 Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Monitoring spirometry-like parameters in mice with house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM) Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002 Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Do the current house dust mite-driven models really mimic allergic asthma? Source: Eur Respir J 2010; 36: 1220-1221 Year: 2010 Cigarette smoke exposure facilitates allergic sensitization to house dust mite and aggravates the asthmatic phenotype in mice Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 A house dust mite-induced asthma model in transcutaneously sensitized mice Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Oral presentation: Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Allergen exposure in nondog and nonhouse dust mite sensitized atopic asthmatic subjects; effect on bronchial reactivity Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Exhaled NO in steroid naive house dust mite allergic asthmatics Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001 High-altitude treatment in atopic and nonatopic patients with severe asthma Source: Eur Respir J 2012; 40: 1374-1380 Year: 2012 Polymorphisms of IL-4/IL4R alpha genes in house dust mite allergic asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 141s Year: 2005